Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
PLoS Negl Trop Dis. 2018 Feb 9;12(2):e0006209. doi: 10.1371/journal.pntd.0006209. eCollection 2018 Feb.
PLoS Negl Trop Dis. 2018.
PMID: 29425203
Free PMC article.
Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates.
Ong EZ, Budigi Y, Tan HC, Robinson LN, Rowley KJ, Winnett A, Hobbie S, Shriver Z, Babcock GJ, Ooi EE.
Ong EZ, et al. Among authors: budigi y.
Antiviral Res. 2017 Aug;144:44-47. doi: 10.1016/j.antiviral.2017.05.007. Epub 2017 May 18.
Antiviral Res. 2017.
PMID: 28529000
Free article.
Item in Clipboard
Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human Antibody.
Low JG, Ng JHJ, Ong EZ, Kalimuddin S, Wijaya L, Chan YFZ, Ng DHL, Tan HC, Baglody A, Chionh YH, Lee DCP, Budigi Y, Sasisekharan R, Ooi EE.
Low JG, et al. Among authors: budigi y.
N Engl J Med. 2020 Jul 30;383(5):452-459. doi: 10.1056/NEJMoa2000226.
N Engl J Med. 2020.
PMID: 32726531
Clinical Trial.
Item in Clipboard
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics.
Lee DCP, Raman R, Ghafar NA, Budigi Y.
Lee DCP, et al. Among authors: budigi y.
Antiviral Res. 2021 Aug;192:105105. doi: 10.1016/j.antiviral.2021.105105. Epub 2021 Jun 8.
Antiviral Res. 2021.
PMID: 34111505
Free article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.